RANGE trial of ramucirumab for urothelial cancer
10 Sep 2017
RANGE trial of ramucirumab for urothelial cancer
Small node-negative breast cancers may retain aggressive characteristics
Adaptive TONIC trial of nivolumab combinations for breast cancer
Panitumumab triplet therapy in colorectal cancer
Long term efficacy of denosumab for giant cell bone tumours
Returning to work after cancer
Financial and ethical safety in cancer care
STORM trial to identify genetic variability in metastatic breast cancer
Phase Ib/II trial of combination PD-1 therapy against kidney cancer
The UNICANCER-NeoPAL study of letrozole and palbociclib in luminal cancer
STAMPEDE: Abiraterone acetate plus prednisolone or docetaxel
Problems with care: a patients perspective